Logo for Astria Therapeutics Inc

Astria Therapeutics Investor Relations Material

Latest events

Logo for Astria Therapeutics Inc

Study Result

Astria Therapeutics
Logo for Astria Therapeutics

Q2 2024

12 Aug, 2024
Logo for Astria Therapeutics

Q1 2024

9 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Astria Therapeutics Inc

Access all reports
Astria Therapeutics Inc., formerly known as Catabasis Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases. The company's lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein. Astria Therapeutics is headquartered in Boston, Massachusetts, and its shares are listed on the Nasdaq.